Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance

Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance

Abstract Background The loss of chloroquine (CQ) effectiveness has led to its withdrawal from national policies as a first-line treatment for uncomplicated malaria in several endemic countries, such as the Democratic Republic of Congo (DRC). The K76T mutation on the pfcrt gene has been identified as...

Full description

Bibliographic Details
Main Authors: Doudou M. Yobi, Nadine K. Kayiba, Dieudonné M. Mvumbi, Raphael Boreux, Pius Z. Kabututu, Hippolyte N. T. Situakibanza, Joris L. Likwela, Patrick De Mol, Emile W. Okitolonda, Niko Speybroeck, Georges L. Mvumbi, Marie-Pierre Hayette
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Malaria Journal
Subjects:
Molecular
Surveillance
Resistance
Chloroquine
Amodiaquine
DRC
Online Access:http://link.springer.com/article/10.1186/s12936-020-03192-x

Internet

http://link.springer.com/article/10.1186/s12936-020-03192-x

Similar Items